During the past decade, LMU Munchen, Hamatopoetische Zell - Transplantation conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "LMU Munchen, Hamatopoetische Zell - Transplantation" are "Aspergillosis" (1 trials) and "Candidiasis" (1 trials). Many other conditions were trialed in "LMU Munchen, Hamatopoetische Zell - Transplantation" in a lesser frequency.

Most popular intervention types in "LMU Munchen, Hamatopoetische Zell - Transplantation" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "FK463" (2 trials). Other intervention names were less common.

The vast majority of trials in "LMU Munchen, Hamatopoetische Zell - Transplantation" are 2 trials for "All" genders.

Currently, there are NaN active trials in "LMU Munchen, Hamatopoetische Zell - Transplantation". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in LMU Munchen, Hamatopoetische Zell - Transplantation, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in LMU Munchen, Hamatopoetische Zell - Transplantation, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".